IRON earnings date and last-quarter result: last quarter beat, P/E -11.19. Updated 2026-07-23.
Disc Medicine (IRON) Research Hub
Disc Medicine (IRON) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 77.66 USD (+4.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -11.19, market cap 2.83B. This hub links to the full technical, earnings and options research available for IRON.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 77.66 USD (+4.23%) |
| 52-week range | 55.175 USD – 83.63 USD |
| Trend regime | Range |
| 14-day RSI | 69.8 (Bullish) |
| Trailing P/E | -11.19 |
| Market cap | 2.83B |
| Dividend yield | 0.00% |
Available research for IRON
Covered Call on IRON: how it works, illustrative setup around the real 77.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IRON: how it works, illustrative setup around the real 77.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IRON: how it works, illustrative setup around the real 77.66 USD price, max profit/loss, breakeven and when to use it. Educational.
IRON technical analysis: range, last 77.66 USD, RSI 69.8, 52w range 55.175 USD–83.63 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IRON in?
Disc Medicine (IRON) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IRON in an uptrend or downtrend?
As of 2026-10-26, IRON is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IRON's trailing P/E ratio?
IRON's trailing P/E is -11.19, with a market cap of 2.83B. See the earnings research page for full valuation detail.